184 related articles for article (PubMed ID: 37133714)
1. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis.
Lian BS; Ha JH; Sultana R; Chan LCE; Choo KJL; Yeo YW; Lee HY
Am J Clin Dermatol; 2023 Jul; 24(4):637-647. PubMed ID: 37133714
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic management of DRESS: a retrospective study of 38 cases.
Funck-Brentano E; Duong TA; Bouvresse S; Bagot M; Wolkenstein P; Roujeau JC; Chosidow O; Valeyrie-Allanore L
J Am Acad Dermatol; 2015 Feb; 72(2):246-52. PubMed ID: 25592341
[TBL] [Abstract][Full Text] [Related]
3. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
Lee JW; Yu DA; Cho S; Youn SW; Kwon O
J Dermatol; 2023 Jun; 50(6):814-819. PubMed ID: 36651019
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Tan K; Testro A
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36944441
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor.
Kim S; Joo EJ; Kim UJ; Kim JH; Kim B; Lee HJ; Chae SW; Kim HN; Cheong HS
Asian Pac J Allergy Immunol; 2022 Dec; 40(4):418-421. PubMed ID: 32170921
[TBL] [Abstract][Full Text] [Related]
6. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692
[TBL] [Abstract][Full Text] [Related]
7. Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab.
Chua GT; Rosa Duque JS; Chong PCY; Lee PPW; Lau YL; Ho MHK
Eur Ann Allergy Clin Immunol; 2018 Nov; 50(6):273-276. PubMed ID: 29384118
[TBL] [Abstract][Full Text] [Related]
8. Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Tohyama M; Hashimoto K; Oda F; Namba C; Sayama K
J Dermatol; 2020 May; 47(5):476-482. PubMed ID: 32162382
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, treatment outcomes and prognostic factors of allopurinol-induced DRESS in 52 patients.
Liu Q; Zhao S; Chen W
J Clin Pharm Ther; 2022 Sep; 47(9):1368-1378. PubMed ID: 35971667
[TBL] [Abstract][Full Text] [Related]
10. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised.
Nam YH; Park MR; Nam HJ; Lee SK; Kim KH; Roh MS; Um SJ; Son CH
Allergol Immunopathol (Madr); 2015; 43(1):19-24. PubMed ID: 24388810
[TBL] [Abstract][Full Text] [Related]
11. DRESS syndrome: a detailed insight.
Behera SK; Das S; Xavier AS; Selvarajan S
Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
[TBL] [Abstract][Full Text] [Related]
12. Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases.
Kridin K; Brüggen MC; Walsh S; Bensaid B; Ranki A; Oppel E; Meyersburg D; Chua SL; Seeli C; Sandberg H; French LE; Vorobyev A; Ingen-Housz-Oro S
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):753-762. PubMed ID: 36479739
[TBL] [Abstract][Full Text] [Related]
13. Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report.
Wang L; Li LF
Medicine (Baltimore); 2017 Mar; 96(11):e6346. PubMed ID: 28296768
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine.
Su HJ; Chen CB; Yeh TY; Chung WH
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):674-681. PubMed ID: 34400311
[TBL] [Abstract][Full Text] [Related]
15. Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review.
Gottlieb M; Figlewicz MR; Rabah W; Buddan D; Long B
Am J Emerg Med; 2022 Jun; 56():1-6. PubMed ID: 35338896
[TBL] [Abstract][Full Text] [Related]
16. Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes.
Mizukawa Y; Hama N; Miyagawa F; Takahashi H; Ogawa Y; Kurata M; Asada H; Abe R; Shiohara T
J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3169-3178.e7. PubMed ID: 37437776
[TBL] [Abstract][Full Text] [Related]
17. Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: A systematic review of the literature.
Kim GY; Anderson KR; Davis DMR; Hand JL; Tollefson MM
J Am Acad Dermatol; 2020 Nov; 83(5):1323-1330. PubMed ID: 32247873
[TBL] [Abstract][Full Text] [Related]
18. Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.
Rubin L; Talmon A; Ribak Y; Kessler A; Martin Y; Haran TK; Shamriz O; Adini I; Tal Y
Front Immunol; 2023; 14():1134178. PubMed ID: 37187735
[TBL] [Abstract][Full Text] [Related]
19. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Cardones AR
Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.
Sharifzadeh S; Mohammadpour AH; Tavanaee A; Elyasi S
Eur J Clin Pharmacol; 2021 Mar; 77(3):275-289. PubMed ID: 33025080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
